News
CHARLOTTE, N.C., June 10, 2025 (GLOBE NEWSWIRE) -- Magnera Corporation (NYSE: MAGN) today announced it will be added to the broad-market Russell 3000 ® Index following the annual reconstitution of the ...
Having previously identified a panel of candidate mRNA biomarkers with potential clinical relevance, Mainz Biomed will now begin the verification process in collaboration with Crown Bioscience, a ...
TAIPEI (Taiwan News) — The Ministry of National Defense tracked 16 Chinese military aircraft, eight naval vessels, and one official ship around Taiwan between 6 a.m. on Thursday and 6 a.m. on Friday.
TAIPEI (Taiwan News) — A US intelligence report says China may try to seize Taiwan’s outlying islands to pressure Taipei and test Washington. The US Defense Intelligence Agency, DIA, released its ...
Report Ocean has published a new report on the Saudi Arabia Telecom Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...
TAIPEI (Taiwan News) — GIS Chair Chou Hsien-ying (周賢穎) said Thursday that although 80% of the company's clients are from the US, only 20–30% of shipments go directly to the US, minimizing exposure to ...
Blade Air Mobility provides air transportation and logistics for hospitals across the United States, where it is one of the largest transporters of human organs for transplant, and for passengers, ...
Shareholders are invited to participate by live audio webcast at https://www.dorel.com/pages/shareholder-information Shareholders will have the ability to interact ...
SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...
Live webcasts and recordings of these presentations will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com.
At present, there is no ICI-based drug combination for the treatment of advanced MSS colorectal cancer, which is a cold tumor. Studies have shown that epigenetic regulators such as class I HDAC ...
This open-label, multicenter, randomized controlled trial (RCT) was conducted in China to compare the efficacy and safety of satri-cel versus standard of care (SOC) in CLDN18.2 positive, advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results